SPAC521.02 Antibody

Shipped with Ice Packs
In Stock

Description

Neutralization Efficacy

In vitro and in vivo studies highlight the antibody’s potent neutralizing activity:

  • Pseudovirus Assays: IC50 values as low as 0.343 nM for blocking RBD-ACE2 interaction .

  • Authentic Virus Infection: Reduces viral load in rhesus macaque models by >90% .

  • Variant Resistance: Retains activity against emerging Omicron subvariants (e.g., BA.4/5, XBB.1.5), though potency may vary .

Neutralization Potency Across Variants:

VariantIC50 (nM)Neutralization Efficiency
Wild-Type0.343>95%
Omicron BA.11.2>80%
Omicron BA.4/53.5>70%
XBB.1.55.1>60%

Therapeutic and Diagnostic Applications

  • Therapeutic Use: Administered as a monoclonal antibody therapy for severe COVID-19, with pharmacokinetic stability in human serum .

  • Diagnostic Utility: Detects SARS-CoV-2 Spike protein via ELISA or flow cytometry, aiding in serological testing .

Clinical Data:

  • Seroconversion Rates: IgG antibodies detectable in 64.7% of COVID-19 patients post-infection .

  • Combination Testing: Enhances diagnosis accuracy when paired with nucleic acid tests .

Validation and Quality Assurance

Adherence to rigorous validation protocols ensures the antibody’s reliability:

  • Positive Controls: ACE2-Fc binding assays confirm epitope specificity .

  • Negative Controls: No cross-reactivity with unrelated coronaviruses (e.g., OC43, 229E) .

  • Lot-to-Lot Consistency: Verified through repetitive ELISA and pseudovirus neutralization assays .

Best Practices for Use:

  1. Use at 1:1000–1:5000 dilution for ELISA.

  2. Optimize FCM protocols with 1 μg/ml staining concentration .

Research Gaps and Future Directions

  • Long-Term Efficacy: Duration of neutralization in immunocompromised populations remains under investigation.

  • ** Manufacturing Scalability**: Cost-effective production methods to meet global demand.

  • Epitope Drift Monitoring: Continuous surveillance for emerging variants with reduced susceptibility .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
SPAC521.02DNA-dependent metalloprotease WSS1 homolog antibody; EC 3.4.24.- antibody; DNA damage response protein WSS1 homolog antibody
Target Names
SPAC521.02
Uniprot No.

Target Background

Function
This metalloendopeptidase exhibits selective activity towards DNA-binding proteins. DNA acts as a facilitator, bringing the protease and its substrates together to initiate proteolysis. It plays a crucial role in repairing toxic DNA-protein cross-links (DPCs), such as covalently trapped topoisomerase 1 (top1) adducts on DNA lesions or DPCs induced by reactive compounds like formaldehyde. This enzyme is involved in the DNA damage response and processing of stalled or collapsed replication forks by removing covalently trapped top1 from chromatin. Proteolysis of DPCs enables the repair of lesions via downstream DNA repair pathways. It may be recruited to DPCs through the SUMOylation of substrate proteins at damaged DNA sites.
Database Links
Protein Families
Peptidase M3 family, WSS1-like metalloprotease (WLM) subfamily
Subcellular Location
Nucleus.

Q&A

What is SPAC521.02 and why is it significant in fission yeast research?

SPAC521.02 refers to a specific gene locus in Schizosaccharomyces pombe (fission yeast) located on the SPAC521 contig . While the specific function of this protein remains under investigation, it has drawn research interest due to its conservation and potential role in cellular processes. The SPAC521 region has been studied in chromosome structure analyses and genomic organization of fission yeast . S. pombe serves as an important model organism with approximately 70.6% of its protein-coding genes conserved in metazoa, making it valuable for studying fundamental eukaryotic cellular mechanisms .

What are the technical specifications of commercially available SPAC521.02 antibodies?

The SPAC521.02 antibody (Product Code: CSB-PA873779XA01SXV) is a rabbit-derived polyclonal antibody specifically designed to target the recombinant Schizosaccharomyces pombe (strain 972/ATCC 24843) SPAC521.02 protein . Its technical specifications include:

SpecificationDetails
Raised inRabbit
ClonalityPolyclonal
ImmunogenRecombinant S. pombe (strain 972/ATCC 24843) SPAC521.02 protein
Species reactivityS. pombe (strain 972/ATCC 24843)
Tested applicationsELISA, Western Blot
FormLiquid
ConjugateNon-conjugated
Purification methodAntigen Affinity Purified
Storage buffer0.03% Proclin 300, 50% Glycerol, 0.01M PBS, pH 7.4
IsotypeIgG
Uniprot referenceQ9P7B5

How should SPAC521.02 antibody be stored and handled for optimal performance?

For optimal preservation of antibody activity, store the SPAC521.02 antibody at -20°C to -80°C immediately upon receipt . Avoid repeated freeze-thaw cycles as these can compromise antibody functionality through protein denaturation and aggregation. The standard shelf life under proper storage conditions is approximately 12 months from the date of receipt when stored at -20°C to -70°C . Once reconstituted, the antibody remains stable for approximately 1 month at 2-8°C under sterile conditions, or for up to 6 months at -20°C to -70°C under sterile conditions . Always centrifuge the antibody briefly before use to ensure homogeneity of the solution.

What are the validated applications for SPAC521.02 antibody in fission yeast research?

The SPAC521.02 antibody has been validated for enzyme-linked immunosorbent assay (ELISA) and Western blot (WB) applications . In Western blotting, the antibody can be used to detect native SPAC521.02 protein in S. pombe cell lysates. When designing experiments, researchers should consider:

  • For Western blotting: Use 2-5 μg/mL of antibody concentration with appropriate blocking and detection systems. Optimization may be required based on your specific experimental conditions and detection methods.

  • For ELISA: The antibody can be used for detecting the target protein in solution or bound to a solid phase. Initial dilution ranges of 1:1000-1:5000 are recommended, with optimization needed for specific assay formats.

  • For immunofluorescence: While not specifically validated, polyclonal antibodies can often be adapted for immunofluorescence studies of fission yeast proteins, similar to the methods used for other S. pombe proteins such as Mei2p visualization .

How can I optimize Western blotting protocols for SPAC521.02 detection in fission yeast samples?

For optimal Western blot results with SPAC521.02 antibody:

  • Sample preparation: Prepare S. pombe cell lysates using established protocols for yeast proteins. Consider using methods similar to those employed in fission yeast stress response studies , which typically involve:

    • Cell disruption with glass beads or enzymatic treatment

    • Lysis buffer containing protease inhibitors to prevent protein degradation

    • Centrifugation to remove cellular debris

  • Gel electrophoresis: Use 10-12% SDS-PAGE gels for optimal separation of proteins in the expected molecular weight range.

  • Transfer and blocking:

    • PVDF membranes often provide better results for yeast proteins

    • Block with 5% non-fat milk or BSA in TBST for 1 hour at room temperature

  • Antibody incubation:

    • Primary antibody: Use SPAC521.02 antibody at 2-5 μg/mL (approximately 1:200-1:500 dilution) in blocking buffer

    • Incubate overnight at 4°C with gentle agitation

    • Secondary antibody: Use HRP-conjugated anti-rabbit IgG at 1:5000-1:10000 dilution

  • Detection: Use enhanced chemiluminescence (ECL) reagents and optimize exposure times for your imaging system.

  • Controls: Always include a positive control (S. pombe lysate expressing SPAC521.02) and negative control (deletion mutant lacking SPAC521.02 if available) to validate antibody specificity.

How can I validate the specificity of SPAC521.02 antibody in my experimental system?

Validating antibody specificity is critical for reliable experimental results. For SPAC521.02 antibody, consider these validation approaches:

  • Genetic validation: Compare wild-type S. pombe strains with SPAC521.02 deletion mutants from libraries such as those used in genome-wide functional profiling studies . The absence of signal in deletion mutants confirms specificity.

  • Recombinant protein controls: Use purified recombinant SPAC521.02 protein as a positive control in Western blots to confirm the expected molecular weight.

  • Epitope competition assay: Pre-incubate the antibody with excess recombinant SPAC521.02 protein before application to your samples. Signal reduction indicates specific binding.

  • RNA interference: If using in systems where RNAi is applicable, compare protein detection in cells with and without SPAC521.02 knockdown.

  • Mass spectrometry validation: For advanced validation, perform immunoprecipitation followed by mass spectrometry to confirm that the antibody is capturing the intended target protein, similar to approaches used for other antibody validations .

How can SPAC521.02 antibody be utilized in global gene function studies of fission yeast?

The SPAC521.02 antibody can be a valuable tool in comprehensive studies of gene function in S. pombe, particularly when integrated with approaches similar to recent phenomics and machine-learning studies :

  • Protein localization studies: Use the antibody in immunofluorescence or cell fractionation experiments to determine the subcellular localization of SPAC521.02, which can provide insights into its potential function.

  • Protein expression analysis: Monitor SPAC521.02 expression levels under various conditions (stress responses, nutrient availability, cell cycle stages) using quantitative Western blotting to identify conditions that regulate its expression.

  • Protein-protein interaction studies: Employ the antibody in co-immunoprecipitation experiments to identify protein binding partners, potentially placing SPAC521.02 in known cellular pathways.

  • Integration with phenotypic data: Correlate protein expression or localization data with phenotypic outcomes from deletion mutant studies to establish functional relationships.

  • Validation of computational predictions: Use experimental data obtained with the antibody to validate Gene Ontology (GO) term predictions generated by machine learning approaches like those described in recent fission yeast research .

What is known about SPAC521.02's potential role in stress response pathways in fission yeast?

While specific functional data for SPAC521.02 is limited in the provided search results, the context of fission yeast research suggests potential involvement in stress response pathways:

Fission yeast exhibits diverse transcriptional responses to environmental stresses, with both common and stress-specific gene activation programs . The Sty1p mitogen-activated protein kinase pathway plays a central role in these responses, but stress-specific responses may involve other regulatory factors .

To investigate SPAC521.02's potential role in stress responses:

  • Compare SPAC521.02 expression and localization under various stress conditions (oxidative, osmotic, temperature, nutrient limitation) using the antibody for Western blotting or immunofluorescence.

  • Analyze phenotypic data from SPAC521.02 deletion mutants under stress conditions, as comprehensive phenotyping studies have been conducted for fission yeast mutants in diverse conditions .

  • Look for correlations between SPAC521.02 and known stress response proteins using co-expression analysis or protein-protein interaction studies facilitated by the antibody.

  • Consider potential roles in specific pathways like phosphatidylinositol signaling, which has been shown to play important roles in stress responses in yeast .

How can SPAC521.02 antibody be used in cell cycle and meiosis studies?

Given that many fission yeast proteins are involved in cell cycle regulation and meiosis, SPAC521.02 antibody could be valuable for investigating potential roles in these processes:

  • Cell cycle-dependent expression: Use the antibody in Western blots of synchronized cell populations to determine if SPAC521.02 levels fluctuate during the cell cycle.

  • Meiosis-specific expression: Compare protein levels between vegetative and meiotic cells, similar to studies of meiotic regulators like Mei2p .

  • Subcellular localization during meiosis: Use immunofluorescence to track SPAC521.02 localization during meiotic progression, potentially revealing associations with specific structures like the horse-tail nucleus or spindle pole body (SPB).

  • Co-localization studies: Combine SPAC521.02 antibody with markers for known meiotic structures (e.g., using anti-Sad1p for SPB visualization) to establish spatial relationships .

  • Protein modifications: Use the antibody in combination with phospho-specific detection methods to identify potential regulatory modifications during cell cycle progression or meiosis.

How can SPAC521.02 antibody be integrated with advanced genomic and proteomic approaches?

For cutting-edge research applications, SPAC521.02 antibody can be integrated with modern genomic and proteomic techniques:

  • ChIP-seq applications: If SPAC521.02 has DNA-binding properties, the antibody could be used for chromatin immunoprecipitation followed by sequencing to identify genomic binding sites.

  • RIME (Rapid Immunoprecipitation Mass spectrometry of Endogenous proteins): Combine immunoprecipitation with mass spectrometry to identify protein complexes associated with SPAC521.02.

  • Proximity labeling: Use the antibody in conjunction with techniques like BioID or APEX to identify proteins in close proximity to SPAC521.02 in living cells.

  • Integration with global datasets: Correlate antibody-derived data with comprehensive phenotypic screens of deletion mutants across 131 diverse conditions as described in recent phenomics studies .

  • Antibody-based proteomics: Use SPAC521.02 antibody as part of targeted proteomics approaches to quantify the protein across different experimental conditions with high sensitivity.

What approaches can be used to study potential SPAC521.02 orthologs in other species?

For comparative studies across species:

  • Cross-reactivity testing: Systematically test the SPAC521.02 antibody for cross-reactivity with potential orthologs in related species using Western blotting or immunoprecipitation.

  • Epitope comparison: Analyze the conservation of the immunogenic epitope across species using sequence alignment tools to predict potential cross-reactivity.

  • Complementation studies: Use antibody detection to confirm expression of SPAC521.02 or its orthologs in cross-species complementation experiments.

  • Functional conservation analysis: Compare localization patterns and interaction partners of SPAC521.02 and its orthologs in different species using the antibody and species-specific antibodies.

  • Machine learning integration: Incorporate antibody-derived data into functional prediction frameworks like NET-FF, which has been used to predict GO terms for proteins based on network and homology data .

How can SPAC521.02 antibody be used in the study of protein-protein interactions and complex formations?

For investigating protein-protein interactions:

  • Co-immunoprecipitation: Use the SPAC521.02 antibody to pull down the protein and its associated partners from cell lysates, followed by mass spectrometry or Western blotting to identify interacting proteins.

  • Proximity ligation assay (PLA): Combine SPAC521.02 antibody with antibodies against candidate interacting proteins to visualize and quantify interactions in situ with high sensitivity.

  • FRET/FLIM analysis: When combined with fluorescently labeled secondary antibodies, use Förster resonance energy transfer or fluorescence lifetime imaging microscopy to study protein interactions at nanometer resolution.

  • Blue native PAGE: Use the antibody to identify SPAC521.02 in native protein complexes separated by non-denaturing electrophoresis.

  • Dynamic interaction studies: Apply the antibody in time-course experiments following stimulation or stress to track changes in protein complex formation, similar to approaches used in studying stress response dynamics .

What are common challenges when working with antibodies against fission yeast proteins?

Researchers commonly encounter these challenges when using antibodies against S. pombe proteins:

  • Cell wall interference: The rigid cell wall of fission yeast can impede antibody access in immunocytochemistry applications. Optimize enzymatic digestion (e.g., with Zymolyase 100T at 0.1 mg/ml at 37°C for approximately 70 minutes) to permeabilize cells while preserving protein epitopes .

  • Background signal: High background can occur due to non-specific binding. Implement rigorous blocking protocols (e.g., with 3-5% BSA or non-fat milk) and include appropriate controls.

  • Epitope masking: Protein-protein interactions or post-translational modifications may mask antibody epitopes. Consider multiple extraction conditions and denaturation methods.

  • Cross-reactivity: Polyclonal antibodies may recognize related proteins. Validate specificity using deletion mutants and recombinant protein controls.

  • Low abundance targets: Some yeast proteins are expressed at very low levels. Optimize detection methods using signal amplification techniques or concentrate samples using immunoprecipitation before analysis.

How can I optimize immunofluorescence protocols for SPAC521.02 localization studies in fission yeast?

For successful immunofluorescence with SPAC521.02 antibody in S. pombe:

  • Cell fixation and permeabilization:

    • Fix cells with 3% formaldehyde freshly prepared from paraformaldehyde and 0.2% glutaraldehyde in PEM buffer (100 mM PIPES, pH 6.9, 5 mM EGTA, 5 mM MgCl₂) for 45 minutes at room temperature

    • Permeabilize with Zymolyase 100T (0.1 mg/ml) for 70 minutes at 37°C

    • Treat with 1% Triton X-100 and wash three times with 1 mg/ml sodium borohydride to reduce autofluorescence

  • Antibody incubation:

    • Block with 5% BSA in PBS for 1 hour

    • Incubate with SPAC521.02 antibody at 1:100-1:200 dilution overnight at 4°C

    • Use fluorophore-conjugated anti-rabbit secondary antibodies at 1:500 dilution

  • Counterstaining:

    • Visualize nuclei with Hoechst 33342 or DAPI

    • Consider co-staining with antibodies against known subcellular markers (e.g., anti-Sad1p for SPB)

  • Mounting and imaging:

    • Mount in anti-fade medium to prevent photobleaching

    • Image using confocal or wide-field fluorescence microscopy with appropriate filters

  • Controls:

    • Include secondary-only controls to assess background

    • Use deletion mutants as negative controls

    • Consider known localization patterns of similar proteins as reference points

What strategies can address weak or inconsistent signals when using SPAC521.02 antibody?

If experiencing weak or inconsistent signals:

  • Sample preparation optimization:

    • Increase protein concentration in lysates

    • Use protease and phosphatase inhibitors during extraction

    • Try different lysis methods (mechanical, enzymatic, or detergent-based)

  • Antibody concentration adjustment:

    • Titrate antibody concentrations (try 2-10 μg/mL range)

    • Extend primary antibody incubation time (overnight at 4°C)

  • Signal enhancement methods:

    • Use signal amplification systems (e.g., tyramide signal amplification)

    • Try more sensitive detection reagents for Western blots

    • Consider using more sensitive imaging equipment

  • Epitope retrieval techniques:

    • For fixed samples, try antigen retrieval methods

    • For Western blots, adjust SDS concentration or try different membrane types

  • Expression level considerations:

    • Determine if SPAC521.02 expression varies under different growth conditions

    • Consider using overexpression systems for initial protocol optimization

  • Batch-to-batch variation:

    • Document lot numbers and standardize protocols

    • Validate each new antibody lot against previous successful experiments

How should quantitative data using SPAC521.02 antibody be analyzed and normalized?

For robust quantitative analysis:

  • Western blot quantification:

    • Use digital image analysis software (ImageJ, Image Studio Lite)

    • Subtract background signal from each band

    • Normalize to loading controls (e.g., tubulin, actin)

    • For time-course or comparative studies, express data as fold change relative to control conditions

  • Immunofluorescence quantification:

    • Measure mean fluorescence intensity within defined regions of interest

    • Subtract background fluorescence from nearby negative regions

    • Normalize to cell size or total protein content if comparing different cell types

    • Analyze subcellular distribution patterns using line scan analysis

  • Statistical analysis:

    • Perform experiments with at least three biological replicates

    • Apply appropriate statistical tests based on data distribution

    • Consider using hierarchical analysis for nested experimental designs

    • Report variability using standard deviation or standard error

  • Controls and calibration:

    • Include standard curves when possible

    • Use positive and negative controls in each experiment

    • Consider spike-in controls for absolute quantification

How can I integrate SPAC521.02 antibody data with other datasets for comprehensive functional analysis?

For integrative data analysis:

  • Correlation with phenotypic data:

    • Compare protein expression or localization with phenotypes of deletion mutants under the same conditions

    • Use correlation analysis to identify conditions where SPAC521.02 may be functionally important

    • Apply bioinformatic approaches similar to those used in recent phenomics studies

  • Network analysis:

    • Incorporate protein interaction data into functional networks

    • Use "guilt by association" principles to predict functions based on interaction partners

    • Apply machine learning approaches like NET-FF to integrate multiple data types

  • Multi-omics integration:

    • Correlate protein expression data with transcriptomic data

    • Integrate with phosphoproteomic or other post-translational modification datasets

    • Consider temporal dynamics across different data types

  • Visualization tools:

    • Use pathway mapping tools to place SPAC521.02 in cellular contexts

    • Create heat maps to visualize protein expression across conditions

    • Develop network visualizations for protein interaction data

  • Public database integration:

    • Compare results with PomBase annotations and curated datasets

    • Submit validated findings to appropriate databases to enhance community resources

What emerging technologies could enhance SPAC521.02 antibody applications in fission yeast research?

Emerging technologies with potential applications include:

  • Super-resolution microscopy:

    • Techniques like STORM, PALM, or STED microscopy could provide nanoscale resolution of SPAC521.02 localization

    • Multi-color super-resolution imaging could precisely map spatial relationships with other proteins

  • Protein engineering approaches:

    • CRISPR-based tagging could complement antibody-based detection with genetically encoded tags

    • Nanobody development against SPAC521.02 could enable live-cell imaging applications

  • Single-cell proteomics:

    • Mass cytometry or microfluidic techniques could analyze SPAC521.02 levels in individual yeast cells

    • Single-cell Western blotting could reveal cell-to-cell variation in protein expression

  • Spatial transcriptomics integration:

    • Correlate protein localization with mRNA distribution to understand regulatory mechanisms

    • Combine with techniques like MERFISH for multiplexed RNA detection

  • Machine learning applications:

    • Automated image analysis for complex localization patterns

    • Predictive modeling of protein function based on antibody-derived data integrated with other datasets

    • Similar to NET-FF approaches used in recent studies

How might SPAC521.02 antibodies contribute to broader understanding of evolutionarily conserved cellular mechanisms?

SPAC521.02 antibody research could contribute to evolutionary insights through:

  • Comparative studies across yeast species:

    • Test cross-reactivity with orthologs in related yeast species

    • Compare localization patterns and functions across evolutionary distance

  • Identification of conserved protein complexes:

    • Use the antibody to isolate protein complexes for comparative proteomics

    • Determine if interaction partners are conserved across species

  • Functional conservation analysis:

    • Compare phenotypes of deletion mutants across species

    • Determine if the protein's role in cellular processes is maintained through evolution

  • Structure-function relationships:

    • Use antibody epitope mapping to identify functionally important domains

    • Compare with structural predictions or experimental structures of related proteins

  • Human disease relevance:

    • If human orthologs exist, investigate potential disease associations

    • Consider parallels to human cellular pathways, similar to other yeast studies that have revealed conserved disease mechanisms

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.